1. Executive Summary
1.1. Global Molecular Diagnostics Market Snapshot 2025 and 2032
1.2. Market Opportunity Assessment, 2025-2032, US$ Bn
1.3. Key Market Trends
1.4. Industry Developments and Key Market Events
1.5. Demand Side and Supply Side Analysis
1.6. PMR Analysis and Recommendations
2. Market Overview
2.1. Market Scope and Definitions
2.2. Value Chain Analysis
2.3. Macro-Economic Factors
2.3.1. Global GDP Outlook
2.3.2. Global GDP Outlook
2.3.3. Global economic Growth Forecast
2.3.4. Global Urbanization Growth
2.3.5. Other Macro-economic Factors
2.4. Forecast Factors – Relevance and Impact
2.5. COVID-19 Impact Assessment
2.6. PESTLE Analysis
2.7. Porter's Five Forces Analysis
2.8. Geopolitical Tensions: Market Impact
2.9. Regulatory and Technology Landscape
3. Market Dynamics
3.1. Drivers
3.2. Restraints
3.3. Opportunities
3.4. Trends
4. Price Trend Analysis, 2019 – 2032
4.1. Region-wise Price Analysis
4.2. Price by Segments
4.3. Price Impact Factors
5. Global Molecular Diagnostics Market Outlook: Historical (2019 – 2024) and Forecast (2025 – 2032)
5.1. Key Highlights
5.2. Global Molecular Diagnostics Market Outlook: Product Type
5.2.1. Introduction/Key Findings
5.2.2. Historical Market Size (US$ Bn) Analysis by Product Type, 2019-2024
5.2.3. Current Market Size (US$ Bn) Forecast, by Product Type, 2025-2032
5.2.3.1. Instruments
5.2.3.1.1. Polymerase Chain Reaction (PCR) Systems
5.2.3.1.2. Hybridization (In-Situ Hybridization & Fish) Systems
5.2.3.1.3. DNA Sequencing and Next-Generation Sequencing Platforms
5.2.3.1.4. Microarrays
5.2.3.2. Reagent
5.2.3.2.1. Antibodies
5.2.3.2.2. DNA Template
5.2.3.2.3. DNA Polymerase
5.2.3.2.4. Oligonucleotide Primers
5.2.3.2.5. Deoxyribonucleotide Triphosphate (dNTPs)
5.2.3.2.6. Buffer
5.2.3.3. Assay Kits
5.2.3.4. Consumables
5.2.4. Market Attractiveness Analysis: Product Type
5.3. Global Molecular Diagnostics Market Outlook: Disease Area
5.3.1. Introduction/Key Findings
5.3.2. Historical Market Size (US$ Bn) Analysis by Disease Area, 2019-2024
5.3.3. Current Market Size (US$ Bn) Forecast, by Disease Area, 2025-2032
5.3.3.1. Infectious Disease
5.3.3.2. Diabetes
5.3.3.3. Cardiology
5.3.3.4. Oncology
5.3.3.5. Nephrology
5.3.3.6. Autoimmune Disease
5.3.3.7. Dermatology
5.3.3.8. Wound Care
5.3.3.9. Others
5.3.4. Market Attractiveness Analysis: Disease Area
5.4. Global Molecular Diagnostics Market Outlook: End-use
5.4.1. Introduction/Key Findings
5.4.2. Historical Market Size (US$ Bn) Analysis by End-use, 2019-2024
5.4.3. Current Market Size (US$ Bn) Forecast, by End-use, 2025-2032
5.4.3.1. Hospitals & Clinics
5.4.3.2. Diagnostics Laboratories
5.4.3.3. Academic and Research Institutes
5.4.3.4. Biopharmaceutical Companies
5.4.4. Market Attractiveness Analysis: End-use
6. Global Molecular Diagnostics Market Outlook: Region
6.1. Key Highlights
6.2. Historical Market Size (US$ Bn) Analysis by Region, 2019-2024
6.3. Current Market Size (US$ Bn) Forecast, by Region, 2025-2032
6.3.1. North America
6.3.2. Europe
6.3.3. East Asia
6.3.4. South Asia & Oceania
6.3.5. Latin America
6.3.6. Middle East & Africa
6.4. Market Attractiveness Analysis: Region
7. North America Molecular Diagnostics Market Outlook: Historical (2019 – 2024) and Forecast (2025 – 2032)
7.1. Key Highlights
7.2. Pricing Analysis
7.3. North America Market Size (US$ Bn) Forecast, by Country, 2025-2032
7.3.1. U.S.
7.3.2. Canada
7.4. North America Market Size (US$ Bn) Forecast, by Product Type, 2025-2032
7.4.1. Instruments
7.4.1.1. Polymerase Chain Reaction (PCR) Systems
7.4.1.2. Hybridization (In-Situ Hybridization & Fish) Systems
7.4.1.3. DNA Sequencing and Next-Generation Sequencing Platforms
7.4.1.4. Microarrays
7.4.2. Reagent
7.4.2.1. Antibodies
7.4.2.2. DNA Template
7.4.2.3. DNA Polymerase
7.4.2.4. Oligonucleotide Primers
7.4.2.5. Deoxyribonucleotide Triphosphate (dNTPs)
7.4.2.6. Buffer
7.4.3. Assay Kits
7.4.4. Consumables
7.5. North America Market Size (US$ Bn) Forecast, by Disease Area, 2025-2032
7.5.1. Infectious Disease
7.5.2. Diabetes
7.5.3. Cardiology
7.5.4. Oncology
7.5.5. Nephrology
7.5.6. Autoimmune Disease
7.5.7. Dermatology
7.5.8. Wound Care
7.5.9. Others
7.6. North America Market Size (US$ Bn) Forecast, by End-use, 2025-2032
7.6.1. Hospitals & Clinics
7.6.2. Diagnostics Laboratories
7.6.3. Academic and Research Institutes
7.6.4. Biopharmaceutical Companies
8. Europe Molecular Diagnostics Market Outlook: Historical (2019 – 2024) and Forecast (2025 – 2032)
8.1. Key Highlights
8.2. Pricing Analysis
8.3. Europe Market Size (US$ Bn) Forecast, by Country, 2025-2032
8.3.1. Germany
8.3.2. Italy
8.3.3. France
8.3.4. U.K.
8.3.5. Spain
8.3.6. Russia
8.3.7. Rest of Europe
8.4. Europe Market Size (US$ Bn) Forecast, by Product Type, 2025-2032
8.4.1. Instruments
8.4.1.1. Polymerase Chain Reaction (PCR) Systems
8.4.1.2. Hybridization (In-Situ Hybridization & Fish) Systems
8.4.1.3. DNA Sequencing and Next-Generation Sequencing Platforms
8.4.1.4. Microarrays
8.4.2. Reagent
8.4.2.1. Antibodies
8.4.2.2. DNA Template
8.4.2.3. DNA Polymerase
8.4.2.4. Oligonucleotide Primers
8.4.2.5. Deoxyribonucleotide Triphosphate (dNTPs)
8.4.2.6. Buffer
8.4.3. Assay Kits
8.4.4. Consumables
8.5. Europe Market Size (US$ Bn) Forecast, by Disease Area, 2025-2032
8.5.1. Infectious Disease
8.5.2. Diabetes
8.5.3. Cardiology
8.5.4. Oncology
8.5.5. Nephrology
8.5.6. Autoimmune Disease
8.5.7. Dermatology
8.5.8. Wound Care
8.5.9. Others
8.6. Europe Market Size (US$ Bn) Forecast, by End-use, 2025-2032
8.6.1. Hospitals & Clinics
8.6.2. Diagnostics Laboratories
8.6.3. Academic and Research Institutes
8.6.4. Biopharmaceutical Companies
9. East Asia Molecular Diagnostics Market Outlook: Historical (2019 – 2024) and Forecast (2025 – 2032)
9.1. Key Highlights
9.2. Pricing Analysis
9.3. East Asia Market Size (US$ Bn) Forecast, by Country, 2025-2032
9.3.1. China
9.3.2. Japan
9.3.3. South Korea
9.4. East Asia Market Size (US$ Bn) Forecast, by Product Type, 2025-2032
9.4.1. Instruments
9.4.1.1. Polymerase Chain Reaction (PCR) Systems
9.4.1.2. Hybridization (In-Situ Hybridization & Fish) Systems
9.4.1.3. DNA Sequencing and Next-Generation Sequencing Platforms
9.4.1.4. Microarrays
9.4.2. Reagent
9.4.2.1. Antibodies
9.4.2.2. DNA Template
9.4.2.3. DNA Polymerase
9.4.2.4. Oligonucleotide Primers
9.4.2.5. Deoxyribonucleotide Triphosphate (dNTPs)
9.4.2.6. Buffer
9.4.3. Assay Kits
9.4.4. Consumables
9.5. East Asia Market Size (US$ Bn) Forecast, by Disease Area, 2025-2032
9.5.1. Infectious Disease
9.5.2. Diabetes
9.5.3. Cardiology
9.5.4. Oncology
9.5.5. Nephrology
9.5.6. Autoimmune Disease
9.5.7. Dermatology
9.5.8. Wound Care
9.5.9. Others
9.6. East Asia Market Size (US$ Bn) Forecast, by End-use, 2025-2032
9.6.1. Hospitals & Clinics
9.6.2. Diagnostics Laboratories
9.6.3. Academic and Research Institutes
9.6.4. Biopharmaceutical Companies
10. South Asia & Oceania Molecular Diagnostics Market Outlook: Historical (2019 – 2024) and Forecast (2025 – 2032)
10.1. Key Highlights
10.2. Pricing Analysis
10.3. South Asia & Oceania Market Size (US$ Bn) Forecast, by Country, 2025-2032
10.3.1. India
10.3.2. Southeast Asia
10.3.3. ANZ
10.3.4. Rest of SAO
10.4. South Asia & Oceania Market Size (US$ Bn) Forecast, by Product Type, 2025-2032
10.4.1. Instruments
10.4.1.1. Polymerase Chain Reaction (PCR) Systems
10.4.1.2. Hybridization (In-Situ Hybridization & Fish) Systems
10.4.1.3. DNA Sequencing and Next-Generation Sequencing Platforms
10.4.1.4. Microarrays
10.4.2. Reagent
10.4.2.1. Antibodies
10.4.2.2. DNA Template
10.4.2.3. DNA Polymerase
10.4.2.4. Oligonucleotide Primers
10.4.2.5. Deoxyribonucleotide Triphosphate (dNTPs)
10.4.2.6. Buffer
10.4.3. Assay Kits
10.4.4. Consumables
10.5. South Asia & Oceania Market Size (US$ Bn) Forecast, by Disease Area, 2025-2032
10.5.1. Infectious Disease
10.5.2. Diabetes
10.5.3. Cardiology
10.5.4. Oncology
10.5.5. Nephrology
10.5.6. Autoimmune Disease
10.5.7. Dermatology
10.5.8. Wound Care
10.5.9. Others
10.6. South Asia & Oceania Market Size (US$ Bn) Forecast, by End-use, 2025-2032
10.6.1. Hospitals & Clinics
10.6.2. Diagnostics Laboratories
10.6.3. Academic and Research Institutes
10.6.4. Biopharmaceutical Companies
11. Latin America Molecular Diagnostics Market Outlook: Historical (2019 – 2024) and Forecast (2025 – 2032)
11.1. Key Highlights
11.2. Pricing Analysis
11.3. Latin America Market Size (US$ Bn) Forecast, by Country, 2025-2032
11.3.1. Brazil
11.3.2. Mexico
11.3.3. Rest of LATAM
11.4. Latin America Market Size (US$ Bn) Forecast, by Product Type, 2025-2032
11.4.1. Instruments
11.4.1.1. Polymerase Chain Reaction (PCR) Systems
11.4.1.2. Hybridization (In-Situ Hybridization & Fish) Systems
11.4.1.3. DNA Sequencing and Next-Generation Sequencing Platforms
11.4.1.4. Microarrays
11.4.2. Reagent
11.4.2.1. Antibodies
11.4.2.2. DNA Template
11.4.2.3. DNA Polymerase
11.4.2.4. Oligonucleotide Primers
11.4.2.5. Deoxyribonucleotide Triphosphate (dNTPs)
11.4.2.6. Buffer
11.4.3. Assay Kits
11.4.4. Consumables
11.5. Latin America Market Size (US$ Bn) Forecast, by Disease Area, 2025-2032
11.5.1. Infectious Disease
11.5.2. Diabetes
11.5.3. Cardiology
11.5.4. Oncology
11.5.5. Nephrology
11.5.6. Autoimmune Disease
11.5.7. Dermatology
11.5.8. Wound Care
11.5.9. Others
11.6. Latin America Market Size (US$ Bn) Forecast, by End-use, 2025-2032
11.6.1. Hospitals & Clinics
11.6.2. Diagnostics Laboratories
11.6.3. Academic and Research Institutes
11.6.4. Biopharmaceutical Companies
12. Middle East & Africa Molecular Diagnostics Market Outlook: Historical (2019 – 2024) and Forecast (2025 – 2032)
12.1. Key Highlights
12.2. Pricing Analysis
12.3. Middle East & Africa Market Size (US$ Bn) Forecast, by Country, 2025-2032
12.3.1. GCC Countries
12.3.2. South Africa
12.3.3. Northern Africa
12.3.4. Rest of MEA
12.4. Middle East & Africa Market Size (US$ Bn) Forecast, by Product Type, 2025-2032
12.4.1. Instruments
12.4.1.1. Polymerase Chain Reaction (PCR) Systems
12.4.1.2. Hybridization (In-Situ Hybridization & Fish) Systems
12.4.1.3. DNA Sequencing and Next-Generation Sequencing Platforms
12.4.1.4. Microarrays
12.4.2. Reagent
12.4.2.1. Antibodies
12.4.2.2. DNA Template
12.4.2.3. DNA Polymerase
12.4.2.4. Oligonucleotide Primers
12.4.2.5. Deoxyribonucleotide Triphosphate (dNTPs)
12.4.2.6. Buffer
12.4.3. Assay Kits
12.4.4. Consumables
12.5. Middle East & Africa Market Size (US$ Bn) Forecast, by Disease Area, 2025-2032
12.5.1. Infectious Disease
12.5.2. Diabetes
12.5.3. Cardiology
12.5.4. Oncology
12.5.5. Nephrology
12.5.6. Autoimmune Disease
12.5.7. Dermatology
12.5.8. Wound Care
12.5.9. Others
12.6. Middle East & Africa Market Size (US$ Bn) Forecast, by End-use, 2025-2032
12.6.1. Hospitals & Clinics
12.6.2. Diagnostics Laboratories
12.6.3. Academic and Research Institutes
12.6.4. Biopharmaceutical Companies
13. Competition Landscape
13.1. Market Share Analysis, 2024
13.2. Market Structure
13.2.1. Competition Intensity Mapping
13.2.2. Competition Dashboard
13.3. Company Profiles
13.3.1. Becton, Dickinson and Company
13.3.1.1. Company Overview
13.3.1.2. Product Portfolio/Offerings
13.3.1.3. Key Financials
13.3.1.4. SWOT Analysis
13.3.1.5. Company Strategy and Key Developments
13.3.2. Bio-Rad Laboratories In
13.3.3. Merck KgaA
13.3.4. Thermo Fisher Scientific Inc
13.3.5. Agilent Technologies, Inc.
13.3.6. F. Hoffman - La Roche Ltd.
13.3.7. Illumina, Inc.
13.3.8. Qiagen N.V.
13.3.9. Hologic Inc.
13.3.10. Siemens Healthineers AG
13.3.11. Seegene, Inc.
13.3.12. DiaSorin S.p.A
13.3.13. Grifols, S.A.
13.3.14. bioMérieux
13.3.15. QuidelOrtho Corporation
14. Appendix
14.1. Research Methodology
14.2. Research Assumptions
14.3. Acronyms and Abbreviations
